Tuesday, November 10, 2026 at 12:00 PM–1:00 PM EST                        Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

Migraine is a complex, chronic disease that results in significant patient and economic burden. Migraine ranks second worldwide in terms of years lost due to disability. Direct annual all cause healthcare costs for a migraine patient is over twice that of a non-migraine patient. Indirect costs from the impact of the disease on a patient’s ability to function (absenteeism and presenteeism) total over $35B annually.

Therefore, it is important to appropriately manage a person with migraine who experiences greater than 4 attacks a month (or severe disability from at least two attacks a month) and may benefit from preventive therapy. One of the main goals of preventive therapy is to improve function and reduce disability. Utilizing a stratified care approach to preventive migraine treatment is key to accomplish this goal.

Learning Objectives

Dr. Maureen Moriarty, a migraine expert, will:

• Discuss the complexity of migraine disease and the burden of the disease as it relates to function.
• Discuss the treatment guidelines for preventive treatment of migraine, with a focus on a treatment option with updated clinical data for migraine prevention.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

For individuals from the media/press interested in attending, please email media@amcp.org.